Howard J. Weisman

Chief Executive Officer, Kuvatris Therapeutics, Inc.

Companies

Kuvatris Therapeutics, Inc.Board member Aug 12, 2022 to Mar 14, 2024¹
Kuvatris Therapeutics, Inc.Chief executive officer Aug 12, 2022 to Mar 14, 2024¹
Kuvatris Therapeutics, Inc.Chair Aug 30, 2023 to Nov 29, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 12, 2024Shares withheld for tax 2,927 shares at $0.69 of Kuvatris Therapeutics, Inc.³
Jan 29, 2024Sold 372 shares at $0.47 of Kuvatris Therapeutics, Inc.⁴
Nov 27, 2023Sold 162 shares at $1.03 of Kuvatris Therapeutics, Inc.⁵
Oct 27, 2023Sold 8,049 shares at $0.19 of Kuvatris Therapeutics, Inc.⁶
Aug 30, 2023Sold 22,535 shares at $0.45 of Kuvatris Therapeutics, Inc.⁷
Aug 29, 2023Sold 9,596 shares at $0.48 of Kuvatris Therapeutics, Inc.⁷
Aug 28, 2023Sold 12,000 shares at $0.49 of Kuvatris Therapeutics, Inc.⁷
Jul 26, 2023Shares withheld for tax 9,952 shares at $0.72 of Kuvatris Therapeutics, Inc.⁸
Apr 26, 2023Shares withheld for tax 9,952 shares at $1.61 of Kuvatris Therapeutics, Inc.⁹
Apr 13, 2023Granted 180,000 shares of Kuvatris Therapeutics, Inc.¹⁰
Mar 9, 2023Sold 3,495 shares at $1.44 of Kuvatris Therapeutics, Inc.¹¹
Mar 8, 2023Sold 32,397 shares at $1.46 of Kuvatris Therapeutics, Inc.¹¹
Mar 7, 2023Sold 23,551 shares at $1.53 of Kuvatris Therapeutics, Inc.¹²
Mar 6, 2023Sold 13,589 shares at $1.72 of Kuvatris Therapeutics, Inc.¹²
Mar 3, 2023Sold 15,323 shares at $1.90 of Kuvatris Therapeutics, Inc.¹³
Mar 2, 2023Sold 11,679 shares at $1.94 of Kuvatris Therapeutics, Inc.¹³

The numbers on this page point here. Each one links to the record it came from.